MTOR and leiomyosarcoma: Although there is no evidence in sarcomas, it has been described in skin cancer cells that HMGA1 depletion disturbs the activity of the mTOR pathway [50], which is in line with our observations that HMGA1 silencing in leiomyosarcoma cells affects the mTOR pathway.